Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Cancer

These are related to the Cancer news, in which you can learn about the updated information in Cancer, to help you better understand and expand Cancer market. Because the market for Cancer is evolving and changing, so we recommend that you collect our website, and we will show you the latest news on a regular basis.
  • New Approval of Olaparib Indication

    New Approval of Olaparib Indication

    2025-03-10

    New Approval of Olaparib IndicationOn January 2nd, AstraZeneca and Merck jointly announced that their PARP inhibitor Lynparza® (Generic name: olaparib) has received approval for a new indication in China. Read More
  • Targeting CDK4/6 in Cancer Drug Development: Challenges and Opportunities

    Targeting CDK4/6 in Cancer Drug Development: Challenges and Opportunities

    2023-09-14

    The cell cycle is tightly regulated to ensure proper cell division and growth. Cyclin-dependent kinases (CDKs) play a crucial role in controlling cell cycle progression. In particular, CDK4 and CDK6 partner with D-type cyclins during the G1 phase to phosphorylate and inactivate the retinoblastoma (R Read More